B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GPR35

MOLECULAR TARGET

G protein-coupled receptor 35

UniProt: Q9HC97NCBI Gene: 285915 compounds

GPR35 (G protein-coupled receptor 35) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GPR35

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Niflumic Acid1.795
2Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.614
3PQQ Cofactor1.614
4Kynurenic Acid1.614
5PQQ Cofactor1.614
6PQQ Cofactor1.614
7myricetin-3-O-galactopyranoside [Supplementary Concept]1.393
8Quercetin1.393
9Furosemide1.393
10amlexanox0.691
11Aprepitant0.691
12Bumetanide0.691
13Emetine0.691
14Firefly Luciferin0.691
15Perphenazine0.691

About GPR35 as a Drug Target

GPR35 (G protein-coupled receptor 35) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented GPR35 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GPR35 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.